News Archive
Hillenbrand revenue for the fourth quarter of 2012 grew 10% to $254 million compared to the same quarter last year. This represents 11% revenue growth on a constant currency basis.
BD, a leading global medical technology company, today announced the commercial availability of the CE-marked PAXgene Blood DNA Tube in Europe. The PAXgene Blood DNA Tube is the first blood collection tube designed specifically for in vitro diagnostic (IVD) genomic DNA testing. The product was developed by PreAnalytiX GmbH, a joint venture between BD and QIAGEN.
On Friday, April 18th PGFX Patent Holdings, operating as Heritage Biosciences, LLC made an asset acquisition of proprietary methods, devices and intellectual property from Orogen Biosciences, Inc.
Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.
The research, published today in Blood, is the first to show the combination of two factors secreted from the environment of the spleen is important in the promotion of leukemia.
› Verified 9 days ago